Form 4: Argan Inc. Executive Receives Stock Options and RSUs

Argan Inc. Chief Financial Officer Joshua Scott Baugher was granted stock options and various forms of restricted stock units on April 8, 2026.

Summary

• Joshua Scott Baugher, Chief Financial Officer of Argan Inc., received a grant of a 10-year option to purchase 208 shares of common stock at an exercise price of $588.28 per share.
• The options vest ratably over three years, starting on April 8, 2027.
• Baugher was also granted Time-Based Restricted Stock Units (TRSUs) covering 126 shares, which vest in equal installments over the next three years, starting April 8, 2027.
• Additionally, Performance-Based Restricted Stock Units (PRSUs) for 142 shares were granted, with vesting contingent on Argan Inc.'s Total Stock Return (TSR) performance relative to 12 peer companies over a three-year period. The payout can range from 0% to 200% of the target shares.
• The filing also details the grant of Earnings Per Share Performance-Based Restricted Stock Units (EPSRSUs) for a target of 1,670 shares. Vesting depends on the sum of EPS for fiscal years 2027-2029 compared to a baseline from fiscal years 2024-2026. The payout ratio for these units can also range from 0% to 200%.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it details standard executive compensation practices involving stock options and RSUs, with performance-based components designed to align executive and shareholder interests. The high exercise price and performance hurdles suggest management's confidence in future growth.

Positives

• Grant of stock options and restricted stock units to a key executive, indicating potential alignment of executive interests with shareholder value.
• Performance-based components of the grants (PRSUs and EPSRSUs) suggest a focus on achieving specific financial and market performance targets.
• Long-term vesting schedules for options and RSUs encourage executive retention and long-term commitment to the company.

Negatives

• The exercise price for the stock options ($588.28) is significantly high, implying a substantial increase in share price is needed for the options to be in-the-money.
• The performance metrics for PRSUs and EPSRSUs are complex and subject to market conditions and board determination, introducing uncertainty in vesting.

Risks

• The vesting of PRSUs is dependent on Argan Inc.'s Total Stock Return (TSR) compared to 12 peer companies, making it susceptible to broader market downturns or underperformance relative to competitors.
• The vesting of EPSRSUs is tied to future earnings per share performance over a three-year period, which is subject to economic conditions, operational execution, and competitive pressures.
• The high exercise price of the stock options means they may not provide significant value to the executive if the stock price does not appreciate substantially.

Future Outlook

The future outlook for Argan Inc. is implicitly tied to the successful vesting of the performance-based restricted stock units (PRSUs and EPSRSUs), which depend on achieving specific Total Stock Return (TSR) and Earnings Per Share (EPS) targets over the next three to four years. The high exercise price of the stock options also suggests management's expectation of significant future share price appreciation.

Industry Context

StockSavvy.ai notes that the structure of these grants, particularly the inclusion of performance-based RSUs tied to relative TSR and absolute EPS growth, is a common practice in the technology and industrial sectors to incentivize executive performance and align their interests with long-term shareholder value creation. The high exercise price on options is also typical for companies anticipating substantial growth.

Comparison to Industry Standards

• The use of a peer group for Total Stock Return (TSR) performance assessment in PRSUs is a standard benchmarking practice across many industries, including technology and industrials, to ensure performance is evaluated relative to competitors.
• The structure of Time-Based Restricted Stock Units (TRSUs) with multi-year vesting is a widely adopted retention tool in publicly traded companies globally.
• The performance metrics for EPSRSUs, focusing on compounded EPS growth over a multi-year period, are also a common metric used by companies to gauge operational efficiency and profitability growth.

Stakeholder Impact

• Shareholders: The grants are designed to incentivize management to increase shareholder value through stock price appreciation and improved financial performance. However, the high exercise price means significant stock growth is needed for these incentives to translate into realized gains for the executive.
• Employees: The focus on performance metrics like EPS and TSR may indirectly influence company-wide operational focus and strategy, potentially impacting employee efforts and outcomes.
• Management: The grants represent significant potential future compensation for the Chief Financial Officer, contingent on meeting specific performance and tenure requirements.

Next Steps

• Vesting of stock options and restricted stock units over the next three to ten years, contingent on continued employment and performance targets.
• Determination of TSR performance relative to peer companies for PRSUs at the end of the three-year performance period.
• Calculation of EPS performance for EPSRSUs at the end of the three-year performance period (fiscal years ending January 31, 2027, 2028, and 2029).

Key Dates

Keywords

Argan Inc., AGX, Form 4, Stock Options, Restricted Stock Units, RSUs, PRSUs, EPSRSUs, Executive Compensation, Beneficial Ownership, Securities Exchange Act